Verapamil attenuates oxidative stress and inﬂammatory responses in cigarette smoke (CS)-induced murine models of acute lung injury and CSE-stimulated RAW 264.7 macrophages via inhibiting the NF-κB pathway-Reference-Cited by-同舟云学术

Verapamil attenuates oxidative stress and inﬂammatory responses in cigarette smoke (CS)-induced murine models of acute lung injury and CSE-stimulated RAW 264.7 macrophages via inhibiting the NF-κB pathway

Published:2022-05 Issue: Volume:149 Page:112783
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Wu Ximei,Hussain Musaddique,Syed Shahzada Khurram,Saadullah Malik,Alqahtani Ali M.,Alqahtani Taha,Aldahish Afaf,Fatima Mobeen,Shaukat Saira,Hussain Liaqat,Jamil Qurratulain,Mukhtar Imran,Khan Kashif-ur-Rehman,Zeng Ling-Hui

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference87 articles.

1. Acute lung injury: a clinical and molecular review;Butt;Arch. Pathol. Lab Med.,2016

2. Acute lung injury - from pathophysiology to treatment;Mokrá;Physiol. Res.,2020

3. Acute lung injury and the acute respiratory distress syndrome: a clinical review;Wheeler;Lancet,2007

4. The acute respiratory distress syndrome;Matthay;J. Clin. Invest,2012

5. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?;Gattinoni;Am. J. Respir. Crit. Care Med.,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cichorium intybus L. significantly alleviates cigarette smoke-induced acute lung injury by lowering NF-κB pathway activation and inflammatory mediators;Heliyon;2023-11

2. Pharmacological and toxicological evaluation of methyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxoide against haloperidol induced Parkinson like symptoms in animal model: In-vitro and in-vivo studies;Toxicology and Applied Pharmacology;2023-10

3. κ-Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway;Evidence-Based Complementary and Alternative Medicine;2022-08-18